Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses

ABSTRACT SARS-CoV-2 causes COVID-19, an acute respiratory distress syndrome (ARDS) characterized by pulmonary edema, viral pneumonia, multiorgan dysfunction, coagulopathy, and inflammation. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) receptors to infect and damage ciliated epithelial cell...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jonas Nascimento Conde, William R. Schutt, Elena E. Gorbunova, Erich R. Mackow
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology 2020-12-01
coleção:	mBio
Assuntos:	ACE2 COVID-19 SARS-CoV-2 coagulopathy endothelial cells endotheliitis
Acesso em linha:	https://journals.asm.org/doi/10.1128/mBio.03185-20
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!